Current NDC auxiliary source row compounder:301

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 71506-074
Product Ndc: 71506-074
Product Ndc Digits: 71506074
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Ketamine Hydrochloride
Proprietary Name Suffix: [empty]
Nonproprietary Name: Ketamine Hydrochloride
Dosage Form Name: INJECTION
Route Name: INTRAMUSCULAR; INTRAVENOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Fresenius Kabi Compounding LLC DBA Fagron Sterile Services
Establishment Name: Fresenius Kabi Compounding LLC DBA Fagron Sterile Services
Establishment Fei: [empty]
Substance Name: KETAMINE HYDROCHLORIDE
Active Ingredients Info: 50 mg/5 mL
History Active Ingredients Raw: KETAMINE HYDROCHLORIDE
History Active Ingredients Info Raw: 50 mg/5 mL
History Dosage Raw: INJECTION
Dea Schedule: CIII
Package Ndc Raw: 71506-074-05
Package Ndc: 71506-074-05
Package Ndc Digits: 7150607405
Package Ndc11: 71506007405
Package Description: 5 mL in 1 SYRINGE (71506-074-05)
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:301
Source Row Number: 301
Source Row Hash: d5f44d1409137b623983a3dd267c857a0125d647d2242e563b7c9ec3612b0c39
Import Run Id: 20261018T022251Z
Loaded At: 2026-10-18 02:29:51

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAMUSCULAR; INTRAVENOUS",
    "PRODUCTNDC": "71506-074",
    "DEASCHEDULE": "CIII",
    "LABELERNAME": "Fresenius Kabi Compounding LLC DBA Fagron Sterile Services",
    "SUBSTANCENAME": "KETAMINE HYDROCHLORIDE",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "71506-074-05",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Ketamine Hydrochloride",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "Ketamine Hydrochloride",
    "PACKAGEDESCRIPTION": "5 mL in 1 SYRINGE (71506-074-05) ",
    "ACTIVEINGREDIENTSINFO": "50 mg/5 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:301
Source Row Number: 301
Status Scope: package
Lookup Ndc: 71506-074-05
Lookup Ndc Digits: 7150607405
Product Ndc: 71506-074
Product Ndc Digits: 71506074
Package Ndc: 71506-074-05
Package Ndc Digits: 7150607405
Package Ndc11: 71506007405
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: d5f44d1409137b623983a3dd267c857a0125d647d2242e563b7c9ec3612b0c39
Import Run Id: 20261018T022251Z
Loaded At: 2026-10-18 02:29:51